WHC is still in active development. Read this to understand our approach.
depiction of MBGVUMXBUGIIBQ-UHFFFAOYSA-N.svg
isomerdesign

J-113,397

Check on isomerdesign

isomerdesign

J-112,444

Check on isomerdesign

drugmap

ATI-17000

Check on drugmap

wiki

J-113,397

Check on wiki

Data

InChI: InChI=1S/C24H37N3O2/c1-2-26-22-12-8-9-13-23(22)27(24(26)29)21-14-15-25(17-20(21)18-28)16-19-10-6-4-3-5-7-11-19/h8-9,12-13,19-21,28H,2-7,10-11,14-18H2,1H3

Synonyms: 1-[(3R,4R)-1-(cyclooctylmethyl)-3-(hydroxymethyl)piperidin-4-yl]-3-ethylbenzimidazol-2-one, 00M5444DIY, 256640-45-6, GTPL1691, CHEMBL357076,CompB, 2H-Benzimidazol-2-one,, AC1NSK6N, (+)-J-113397, J-113,397, J113397, SCHEMBL875219, UNII-00M5444DIY, BDBM50083230, 1-[(3R,4R)-1-cyclooctylmethyl-3-hydroxymethyl-4-piperidyl]-3-ethyl-1,3-dihydro-2H-benzimidazol-2-one, 1-(1-cyclooctylmethyl-3-hydroxymethyl-4-piperidyl)-3-ethyl-1,3-dihydro-2H-benzimidazol-2-one,J-113,397, NCGC00344513-02, ZINC1483900,J-112,444, J 113397, J-113397

Estimated data

Solubility: -3.623 (log(S) in mol/L prediction using SolTranNet)

Addictivity Prediction: 45.1% (prediction based on www.mdpi.com)

Similarities

The following is a set of comparisons to understand the properties of this compound. This is still higly experimental and is still under active development. Please refer to our series of blog posts to fully understand our approach and its limitations. This information is for informational purposes only and should not be construed as medical advice.